Viewing Study NCT01729260


Ignite Creation Date: 2025-12-25 @ 2:06 AM
Ignite Modification Date: 2026-01-26 @ 4:03 PM
Study NCT ID: NCT01729260
Status: COMPLETED
Last Update Posted: 2021-05-07
First Post: 2012-11-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Newly Diagnosed High-Grade Glioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Glioblastoma View
None mebendazole View
None temozolomide View